Article
Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options.
Progress in retinal and eye research - 1 Jan 2022
Brouwer Niels J, Verdijk Robert M, Heegaard Steffen, Marinkovic Marina, Esmaeli Bita, Jager Martine J
Abstract excerpt
Recent developments in oncology have led to a better molecular and cellular understanding of cancer, and the introduction of novel therapies. Conjunctival melanoma (CoM) is a rare but potentially devastating disease. A better understanding of CoM, leading to the development of novel therapies, is urgently needed. CoM is characterized by mutations that have also been identified in cutaneous melanoma, e.g. in BRAF,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
